Xylitol Antioxidant Properties: A Potential Effect for Inflammation Reduction in Menopausal Women?-A Pilot Study
Ilona Górna1, Magdalena Kowalówka1, Barbara Więckowska2
1Department of Bromatology, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznan, Poland.
Current Issues in Molecular Biology
|August 27, 2025
Summary
Replacing sugar with xylitol significantly boosted serum antioxidant capacity in postmenopausal women. This pilot study suggests xylitol may enhance antioxidant defenses, warranting further investigation in larger groups.
Area of Science:
- Nutritional science
- Biochemistry
- Gerontology
Background:
- Oxidative stress is a significant factor in chronic diseases, particularly in postmenopausal women.
- Xylitol, a sugar substitute, possesses potential antioxidant properties that may influence oxidative balance.
Purpose of the Study:
- To evaluate the impact of substituting sucrose with xylitol on serum antioxidant capacity in postmenopausal women.
- To investigate xylitol's role as a potential antioxidant in a specific demographic.
Main Methods:
- A pilot study involving 34 postmenopausal women (aged 50-65).
- Participants consumed varying doses of xylitol (5g, 10g, 15g daily) over six weeks.
- Serum antioxidant capacity was measured using DPPH and ABTS radical scavenging assays.
Main Results:
- A statistically significant increase in serum antioxidant potential was observed across both measurement methods (p < 0.0001).
- Nearly all participants exhibited enhanced free radical neutralization capacity.
- Preliminary analysis indicated potential correlations with manganese, maltose, sucrose, mercury, vitamin A, retinol, and vitamin E.
Conclusions:
- Xylitol shows promise in bolstering antioxidant defense mechanisms in menopausal women.
- Despite a small sample size, the study detected significant effects, suggesting reliability.
- Further research with larger cohorts is recommended to confirm findings and clinical significance.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
255
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
255
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Menopause
248
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
248
Antiasthma Drugs: Methylxanthines
395
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
395


